SAN FRANCISCO (GenomeWeb) – One year after the Garvan Institute of Medical Research in Australia launched startup Genome.One to provide sequencing-based diagnostics for rare disease, the firm has said it will now offer whole-genome sequencing to any curious individual wishing to know his or her genetic risk for a suite of diseases.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.